Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP-Reference-Cited by-同舟云学术

Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP

Published:2021-06-10 Issue:12 Volume:35 Page:3589-3593
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Jachimowicz Ron D.^ORCID,Klapper Wolfram^ORCID,Glehr Gunther,Müller Horst,Haverkamp Heinz^ORCID,Thorns Christoph,Hansmann Martin Leo,Möller Peter,Stein Harald,Rehberg Thorsten,von Tresckow Bastian,Reinhardt H. C.,Borchmann Peter,Chan Fong Chun,Spang Rainer,Scott David W.,Engert Andreas,Steidl Christian^ORCID,Altenbuchinger Michael,Rosenwald Andreas

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-021-01314-1.pdf

Reference13 articles.

1. Eichenauer DA, Engert A, Andre M, Federico M, Illidge T, Hutchings M, et al. Hodgkin’s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25:iii70–5.

2. Scott DW, Chan FC, Hong F, Rogic S, Tan KL, Meissner B, et al. Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma. J Clin Oncol. 2013;31:692–700.

3. Borchmann P, Haverkamp H, Diehl V, Cerny T, Markova J, Ho AD, et al. Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin’s lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group. J Clin Oncol. 2011;29:4234–42.

4. Engert A, Haverkamp H, Kobe C, Markova J, Renner C, Ho A, et al. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin’s lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet 2012;379:1791–9.

5. Jachimowicz RD, Pieper L, Reinke S, Gontarewicz A, Plutschow A, Haverkamp H, et al. Analysis of the tumor microenvironment by whole-slide image analysis identifies low B cell content as a predictor of adverse outcome in advanced-stage classical Hodgkin lymphoma treated with BEACOPP. Haematologica. 2020;106:1684–92.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human leukocyte antigen (HLA) class I expression on Hodgkin–Reed–Sternberg cells is an EBV‐independent major determinant of microenvironment composition in classic Hodgkin lymphoma;HemaSphere;2024-06

2. Machine Learning–Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma;JCO Clinical Cancer Informatics;2024-04

3. Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma;Cancer Research Communications;2023-11-15

4. Genomic profiling for clinical decision making in lymphoid neoplasms;Blood;2022-11-24

5. Predictors of risk of relapse in classic Hodgkin lymphoma;Journal of Clinical Pathology;2022-10-14